Cargando…
Non-adjustment for multiple testing in multi-arm trials of distinct treatments: Rationale and justification
There is currently a lack of consensus and uncertainty about whether one should adjust for multiple testing in multi-arm trials of distinct treatments. A detailed rationale is presented to justify non-adjustment in this situation. We argue that non-adjustment should be the default starting position...
Autores principales: | Parker, Richard A, Weir, Christopher J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534018/ https://www.ncbi.nlm.nih.gov/pubmed/32666813 http://dx.doi.org/10.1177/1740774520941419 |
Ejemplares similares
-
Perspective: Is it Time to Expand Research on “Nuts” to Include “Seeds”? Justifications and Key Considerations
por: George, Elena S, et al.
Publicado: (2022) -
Ethical justification of single-blind and double-blind placebo-controlled response tests in neuropathic pain and N-of-1 treatment paradigm in clinical settings
por: Keppel Hesselink, Jan M, et al.
Publicado: (2019) -
Scientific Rationale for Waiving Clinical Efficacy Testing of Biosimilars
por: Niazi, Sarfaraz
Publicado: (2022) -
Multiplicity adjustments in parallel-group multi-arm trials sharing a control group: Clear guidance is needed
por: Molloy, Síle F., et al.
Publicado: (2022) -
Correcting for multiple-testing in multi-arm trials: is it necessary and is it done?
por: Wason, James M S, et al.
Publicado: (2014)